Also trades as: BRM.V (TSXV) · $vol 0M
BIRMF OTC
BioRem Inc.
1W: +4.5%
1M: -11.5%
3M: +6.5%
YTD: +16.1%
1Y: +65.0%
3Y: +230.0%
5Y: +346.8%
$2.31
-0.08 (-3.23%)
Weekly Expected Move ±9.1%
$2
$2
$2
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$4M
+652.0% ▲
5Y CAGR: +7.8%
Capital Expenditures
$372K
+32.7% ▲
5Y CAGR: +22.4%
Free Cash Flow
$3M
+5372.4% ▲
5Y CAGR: +6.7%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$3M
+296.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2M | $1M | $2M | $2M | $3M |
| Depreciation & Amort. | $354K | $344K | $351K | $383K | $473K |
| Stock-Based Comp. | $20K | $8K | $94K | $128K | $143K |
| Change in Working Capital | $322K | $2M | -$736K | -$3M | -$441K |
| Other Non-Cash Items | $51K | $51K | $40K | $84K | $83K |
| Operating Cash Flow | $3M | $4M | $1M | $490K | $4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$342K | -$76K | -$203K | -$553K | -$372K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$342K | -$76K | -$203K | -$553K | -$372K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$200K | $4M | -$954K | -$623K | -$729K |
| Stock Repurchased | $0 | -$12M | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $1M | $0 | -$775K | $0 |
| Financing Cash Flow | -$200K | -$8M | -$952K | -$1M | -$572K |
| Net Change in Cash | $2M | -$4M | -$696K | -$1M | $3M |
| Cash End of Period | $9M | $4M | $4M | $2M | $5M |
| Free Cash Flow | $3M | $4M | $1M | -$63K | $3M |